Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement, (updated 8/1/2024) and acknowledgement of our Privacy Policy, and Your Privacy Choices and Rights (updated 7/1/2024).

© 2024 Advance Local Media LLC. All rights reserved (About Us). The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Advance Local.

Be sure to SUBSCRIBE to our monthly equipment email to always stay up to date with special offers and new equipment arrivals.

If you purchase a product or register for an account through a link on our site, we may receive compensation. By using this site, you consent to our User Agreement and agree that your clicks, interactions, and personal information may be collected, recorded, and/or stored by us and social media and other third-party partners in accordance with our Privacy Policy.

Need help requesting a quote or have additional questions ? Let us know! Call us at 1.800.248.5882 or you can SEND US AN EMAIL

The BD Alaris PCA Module is a versatile syringe-based device designed for patient-controlled analgesia (PCA). It seamlessly integrates with other BD Alaris modules, offering a comprehensive infusion solution on a single platform. Med One provides BD Alaris PCA Modules that are compatible with the most updated software versions from the manufacturer. Key Features: Syringe-based PCA functionality: Provides pain medication based on patient demand within pre-programmed limits. Broad patient compatibility: Suitable for use on adults, pediatrics, and even neonates. Multiple infusion modes: Supports various delivery methods including primary continuous infusions, PCA dose-only infusions, a combination of both, loading doses, and bolus doses. Enhanced safety (optional): The PCA Pause feature, when used with the EtCO2 module, can help minimize the risk of opioid-induced respiratory depression by pausing delivery after a PCA dose if a patient's EtCO2 levels fall below a preset limit. Modular design: Integrates seamlessly with other BD Alaris modules for a customizable infusion system tailored to specific patient needs.

PartsSource LLC, the fast-growing supplier of replacement parts for hospital medical equipment, is moving its headquarters to Aurora from Twinsburg so it can grow some more. For more than a year, PartsSource looked in vain to find a Twinsburg building that offered at least twice the 25,000 square feet its headquarters on Case Parkway North had, said Ray Dalton, the company's founder, president and chief executive. PartsSource and its seven initial employees moved into that building in February 2003, Dalton said. "We have done four additions, one every year since" to accommodate a growing work force, which now totals 155 in Ohio and California, he said. "It's disappointing to move out of Twinsburg. But we're completely out of space," setting up new employees at folding tables and leasing a parking lot across the street, he said. Officials in Nashville, Phoenix and Jacksonville courted the company that has won several awards for its fast growth before PartsSource bought the former Lucas Aerospace building in Aurora, Dalton said. The 113,000-square-foot building at 777 Lena Drive and its 28-acre campus were vacated soon after the former TRW Corp. sold its aeronautical systems businesses to Goodrich Corp. in 2002, he said. PartsSource expects to open at its new location on May 6. Portage County values the property at $4.8 million for tax purposes. The medical parts supplier plans to occupy the top floor of the Lena Drive building -- doubling its current space to 50,000 square feet -- and to lease the first floor to other tenants until the space is needed, Dalton said. PartsSource, which recently bought a Camarillo, Calif., company, plans to hire 55 to 60 people this year, he said. PartsSource had revenues of $50 million last year and expects sales to reach $75 million this year, Dalton said. "The additional space at our new home will give us the room to grow PartsSource to $250 million in revenue and beyond," he said.